Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Mr. Michael P. HammondIndependent Director | -340,64 | 84,35k | Sale to Issuer | 247,64 | 2,16k | -13,60% |
| 2026-05-15 | Ms. Inga Kristine BealeIndependent Director | -340,64 | 84,35k | Sale to Issuer | 247,64 | 1,92k | -15,05% |
| 2026-05-15 | Mr. Fredric J. TomczykIndependent Director | -340,64 | 84,35k | Sale to Issuer | 247,64 | 1,35k | -20,18% |
| 2026-05-15 | Ms. Jacqueline HuntIndependent Director | -340,64 | 84,35k | Sale to Issuer | 247,64 | 1,35k | -20,18% |
| 2026-05-15 | Mr. Paul Christopher ReillyIndependent Non-Executive Chair | -495,47 | 122,70k | Sale to Issuer | 247,64 | 1,88k | -20,89% |
| 2026-05-15 | Mr. Stephen M. ChipmanIndependent Director | -340,64 | 84,35k | Sale to Issuer | 247,64 | 1,35k | -20,18% |
| 2026-05-15 | Ms. Michelle R. SwanbackIndependent Director | -340,64 | 84,35k | Sale to Issuer | 247,64 | 1,92k | -15,05% |
| 2026-05-15 | Ms. Funmibi F. ChimaIndependent Director | -534,18 | 132,28k | Sale to Issuer | 247,64 | 2,90k | -15,56% |
| 2026-05-06 | Ms. Lucy ClarkePresident of Risk & Broking | 1,90k | 499,34k | Acquisto | 263,37 | 10,47k | 22,11% |
| 2026-05-04 | Mr. Carl Aaron HessCEO & Director | 2,00k | 510,16k | Acquisto | 255,08 | 101,68k | 2,01% |
| 2026-04-21 | Mr. Joseph Stephen KurpisPrincipal Accounting Officer & Controller | -9,58 | 2,85k | Sale to Issuer | 297,64 | 1,51k | -0,63% |
| 2026-04-21 | Ms. Kristy D. BanasChief HR Officer and Head of Marketing & Communication | -105,09 | 31,28k | Sale to Issuer | 297,64 | 11,30k | -0,92% |
| 2026-04-21 | Ms. Alexis FaberCOO | -104,01 | 30,96k | Sale to Issuer | 297,64 | 11,48k | -0,90% |
| 2026-04-21 | Mr. Imran Ahmed QureshiMD, Global Head of Retirement and Global Head of Geographies | -117,61 | 35,00k | Sale to Issuer | 297,64 | 10,29k | -1,13% |
| 2026-04-21 | Ms. Anne PullumGlobal Head of Health & Benefits & Co-head of Corporate Development | -144,26 | 42,94k | Sale to Issuer | 297,64 | 20,33k | -0,70% |
| 2026-04-21 | Mr. Matthew S. FurmanGeneral Counsel | -157,49 | 46,87k | Sale to Issuer | 297,64 | 33,62k | -0,47% |
| 2026-04-21 | Ms. Lucy ClarkePresident of Risk & Broking | -225,50 | 67,12k | Sale to Issuer | 297,64 | 8,58k | -2,56% |
| 2026-04-21 | Ms. Julie Jarecke GebauerPresident of Health, Wealth & Career | -223,11 | 66,41k | Sale to Issuer | 297,64 | 75,51k | -0,29% |
| 2026-04-21 | Mr. Andrew Jay KrasnerCFO & Co-head of Corporate Development | -289,43 | 86,15k | Sale to Issuer | 297,64 | 23,98k | -1,19% |
| 2026-04-21 | Mr. Carl Aaron HessCEO & Director | -1,23k | 367,51k | Sale to Issuer | 297,64 | 99,68k | -1,22% |
| 2026-04-01 | Mr. Andrew Jay KrasnerCFO & Co-head of Corporate Development | -4,58k | 1,33M | Sale to Issuer | 290,70 | 21,87k | -17,33% |
| 2026-04-01 | Ms. Julie Jarecke GebauerPresident of Health, Wealth & Career | -3,70k | 1,07M | Sale to Issuer | 290,70 | 75,09k | -4,69% |
| 2026-04-01 | Ms. Alexis FaberCOO | -2,07k | 602,62k | Sale to Issuer | 290,70 | 10,72k | -16,21% |
| 2026-04-01 | Mr. Matthew S. FurmanGeneral Counsel | -3,46k | 1,01M | Sale to Issuer | 290,70 | 33,44k | -9,37% |
| 2026-04-01 | Mr. Joseph Stephen KurpisPrincipal Accounting Officer & Controller | -248,00 | 72,09k | Sale to Issuer | 290,70 | 1,49k | -14,31% |
| 2026-04-01 | Mr. Imran Ahmed QureshiMD, Global Head of Retirement and Global Head of Geographies | -3,20k | 929,37k | Sale to Issuer | 290,70 | 10,14k | -23,97% |
| 2026-04-01 | Ms. Anne PullumGlobal Head of Health & Benefits & Co-head of Corporate Development | -3,54k | 1,03M | Sale to Issuer | 290,70 | 20,13k | -14,96% |
| 2026-04-01 | Mr. Carl Aaron HessCEO & Director | -31,15k | 9,06M | Sale to Issuer | 290,70 | 98,88k | -23,96% |
| 2026-04-01 | Ms. Kristy D. BanasChief HR Officer and Head of Marketing & Communication | -2,54k | 737,80k | Sale to Issuer | 290,70 | 10,62k | -19,29% |
| 2026-03-03 | Mr. Matthew S. FurmanGeneral Counsel | -3,00k | 912,01k | Vendita | 304,00 | 30,49k | -8,96% |
| 2026-02-26 | Mr. Andrew Jay KrasnerCFO & Co-head of Corporate Development | -68,00 | 0,00 | Other Disposition | - | 26,46k | -0,26% |
| 2026-02-26 | Mr. Carl Aaron HessCEO & Director | -2,10k | 624,55k | Sale to Issuer | 296,84 | 68,71k | -2,97% |
| 2026-02-13 | Ms. Lucy ClarkePresident of Risk & Broking | 3,50k | 996,93k | Acquisto | 284,84 | 8,33k | 72,54% |
| 2026-02-12 | Mr. Michael P. HammondIndependent Director | 241,00 | 67,21k | Acquisto | 278,86 | 1,80k | 15,51% |
| 2025-11-25 | Mr. Imran Ahmed QureshiMD, Global Head of Retirement and Global Head of Geographies | -42,00 | 13,34k | Sale to Issuer | 317,52 | 6,04k | -0,69% |
| 2025-11-25 | Mr. Joseph Stephen KurpisPrincipal Accounting Officer & Controller | -2,00 | 635,04 | Sale to Issuer | 317,52 | 1,02k | -0,20% |
| 2025-11-25 | Mr. Carl Aaron HessCEO & Director | -264,00 | 83,83k | Sale to Issuer | 317,52 | 70,79k | -0,37% |
| 2025-11-25 | Ms. Julie Jarecke GebauerPresident of Health, Wealth & Career | -40,00 | 12,70k | Sale to Issuer | 317,52 | 69,33k | -0,06% |
| 2025-11-25 | Mr. Matthew S. FurmanGeneral Counsel | -51,00 | 16,19k | Sale to Issuer | 317,52 | 33,44k | -0,15% |
| 2025-10-15 | Ms. Lucy ClarkePresident of Risk & Broking | -6,00 | 2,07k | Sale to Issuer | 345,45 | 4,83k | -0,12% |
| 2025-10-01 | Ms. Lucy ClarkePresident of Risk & Broking | -1,89k | 653,59k | Sale to Issuer | 345,45 | 4,83k | -28,13% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
